Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Proactive treatment with calcipotriol reduces recurrence of plaque psoriasis.

Ito K, Koga M, Shibayama Y, Tatematsu S, Nakayama J, Imafuku S.

J Dermatol. 2016 Apr;43(4):402-5. doi: 10.1111/1346-8138.13158. Epub 2015 Oct 5.

PMID:
26434738
2.

Safety, pharmacokinetics, and pharmacodynamics of epratuzumab in Japanese patients with moderate-to-severe systemic lupus erythematosus: Results from a phase 1/2 randomized study.

Tsuru T, Tanaka Y, Kishimoto M, Saito K, Yoshizawa S, Takasaki Y, Miyamura T, Niiro H, Morimoto S, Yamamoto J, Lledo-Garcia R, Shao J, Tatematsu S, Togo O, Koike T.

Mod Rheumatol. 2016;26(1):87-93. doi: 10.3109/14397595.2015.1079292. Epub 2015 Oct 19.

PMID:
26382733
3.

Yellow urticaria in a patient with hepatic cirrhosis.

Chiba T, Hayashi F, Shinmura M, Kiyomatsu M, Tatematsu S, Nakao M, Furue M.

G Ital Dermatol Venereol. 2014 Jun;149(3):381-2. No abstract available.

PMID:
24819772
4.

Urinary biopyrrin: a potential inflammatory marker of atopic dermatitis.

Chiba T, Tatematsu S, Nakao M, Furue M.

Ann Allergy Asthma Immunol. 2014 Feb;112(2):182-3. doi: 10.1016/j.anai.2013.12.011. No abstract available.

PMID:
24468264
5.

Rho-kinase contributes to pressure-induced constriction of renal microvessels.

Homma K, Hayashi K, Wakino S, Tokuyama H, Kanda T, Tatematsu S, Hasegawa K, Fujishima S, Hori S, Saruta T, Itoh H.

Keio J Med. 2014;63(1):1-12. Epub 2014 Jan 16.

6.

Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium.

Tatematsu S, Francis SA, Natarajan P, Rader DJ, Saghatelian A, Brown JD, Michel T, Plutzky J.

Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1788-94. doi: 10.1161/ATVBAHA.113.301300. Epub 2013 May 30.

7.

Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that may involve mechanical stretch.

Hara Y, Wakino S, Tanabe Y, Saito M, Tokuyama H, Washida N, Tatematsu S, Yoshioka K, Homma K, Hasegawa K, Minakuchi H, Fujimura K, Hosoya K, Hayashi K, Nakayama K, Itoh H.

Sci Signal. 2011 Jan 25;4(157):ra3. doi: 10.1126/scisignal.2001227.

8.

Exploration of factors related to hara-kiri as a method of suicide and suicidal behavior.

Takai M, Yamamoto K, Iwamitsu Y, Miyaji S, Yamamoto H, Tatematsu S, Yukawa M, Ide A, Kamijo Y, Soma K, Miyaoka H.

Eur Psychiatry. 2010 Nov;25(7):409-13. doi: 10.1016/j.eurpsy.2009.10.005. Epub 2010 Apr 27.

PMID:
20427155
9.

Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function.

Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Sueyasu K, Washida N, Tokuyama H, Tzukerman M, Skorecki K, Hayashi K, Itoh H.

J Biol Chem. 2010 Apr 23;285(17):13045-56. doi: 10.1074/jbc.M109.067728. Epub 2010 Feb 5.

10.

Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression.

Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Washida N, Tokuyama H, Hayashi K, Itoh H.

Biochem Biophys Res Commun. 2008 Jul 18;372(1):51-6. doi: 10.1016/j.bbrc.2008.04.176. Epub 2008 May 15.

PMID:
18485895
11.

Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats.

Yoshioka K, Wakino S, Homma K, Kanda T, Tatematsu S, Hasegawa K, Sugano N, Ito O, Omata K, Saruta T, Hayashi K.

Obesity (Silver Spring). 2008 May;16(5):965-71. doi: 10.1038/oby.2008.18. Epub 2008 Feb 14.

12.

T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy.

Sugano N, Wakino S, Kanda T, Tatematsu S, Homma K, Yoshioka K, Hasegawa K, Hara Y, Suetsugu Y, Yoshizawa T, Hara Y, Utsunomiya Y, Tokudome G, Hosoya T, Saruta T, Hayashi K.

Kidney Int. 2008 Apr;73(7):826-34. doi: 10.1038/sj.ki.5002793. Epub 2008 Jan 16.

13.

Retention prediction of adrenoreceptor agonists and antagonists on a diol column in hydrophilic interaction chromatography.

Quiming NS, Denola NL, Ueta I, Saito Y, Tatematsu S, Jinno K.

Anal Chim Acta. 2007 Aug 13;598(1):41-50. Epub 2007 Jul 22.

PMID:
17693305
14.

Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.

Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H.

Circ Res. 2007 Jul 20;101(2):e2-10. Epub 2007 Jun 29.

PMID:
17601800
15.

Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.

Tatematsu S, Wakino S, Kanda T, Homma K, Yoshioka K, Hasegawa K, Sugano N, Kimoto M, Saruta T, Hayashi K.

J Am Soc Nephrol. 2007 Mar;18(3):741-9. Epub 2007 Jan 31.

16.

Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells.

Hasegawa K, Wakino S, Tanaka T, Kimoto M, Tatematsu S, Kanda T, Yoshioka K, Homma K, Sugano N, Kurabayashi M, Saruta T, Hayashi K.

Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1488-94. Epub 2006 Mar 30.

PMID:
16574895
17.

Divergent action of calcium channel blockers on ATP-binding cassette protein expression.

Hasegawa K, Wakino S, Kanda T, Yoshioka K, Tatematsu S, Homma K, Takamatsu I, Sugano N, Hayashi K.

J Cardiovasc Pharmacol. 2005 Dec;46(6):787-93.

PMID:
16306803
18.

Rho-kinase as a molecular target for insulin resistance and hypertension.

Kanda T, Wakino S, Homma K, Yoshioka K, Tatematsu S, Hasegawa K, Takamatsu I, Sugano N, Hayashi K, Saruta T.

FASEB J. 2006 Jan;20(1):169-71. Epub 2005 Nov 2.

PMID:
16267124
19.

Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.

Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T.

Hypertens Res. 2005 Mar;28(3):255-62.

PMID:
16097370
20.

Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats--studies in the isolated perfused hydronephrotic kidney.

Hayashi K, Wakino S, Ozawa Y, Homma K, Kanda T, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, Saruta T.

Keio J Med. 2005 Jun;54(2):102-8.

21.

Role of Rho-kinase and p27 in angiotensin II-induced vascular injury.

Kanda T, Hayashi K, Wakino S, Homma K, Yoshioka K, Hasegawa K, Sugano N, Tatematsu S, Takamatsu I, Mitsuhashi T, Saruta T.

Hypertension. 2005 Apr;45(4):724-9. Epub 2005 Feb 7.

PMID:
15699465
22.

Impaired nitric oxide- and endothelium-derived hyperpolarizing factor-dependent dilation of renal afferent arteriole in Dahl salt-sensitive rats.

Ozawa Y, Hayashi K, Kanda T, Homma K, Takamatsu I, Tatematsu S, Yoshioka K, Kumagai H, Wakino S, Saruta T.

Nephrology (Carlton). 2004 Oct;9(5):272-7.

PMID:
15504139
23.

Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.

Wakino S, Hayashi K, Kanda T, Tatematsu S, Homma K, Yoshioka K, Takamatsu I, Saruta T.

Circ Res. 2004 Sep 3;95(5):e45-55. Epub 2004 Aug 12.

PMID:
15308580
24.

Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease.

Homma K, Hayashi K, Kanda T, Yoshioka K, Takamatsu I, Tatematsu S, Kumagai H, Wakino S, Saruta T.

J Hum Hypertens. 2004 Dec;18(12):879-84.

PMID:
15295613
25.

Cell specificity and properties of the C-3 epimerization of Vitamin D3 metabolites.

Kamao M, Tatematsu S, Sawada N, Sakaki T, Hatakeyama S, Kubodera N, Okano T.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):39-42.

PMID:
15225744
26.

Free radical activity depends on underlying vasoconstrictors in renal microcirculation.

Ozawa Y, Hayashi K, Wakino S, Kanda T, Homma K, Takamatsu I, Tatematsu S, Yoshioka K, Saruta T.

Clin Exp Hypertens. 2004 Apr;26(3):219-29.

PMID:
15132300
27.

Role of endothelium-derived hyperpolarizing factor in ACE inhibitor-induced renal vasodilation in vivo.

Matsuda H, Hayashi K, Wakino S, Kubota E, Honda M, Tokuyama H, Takamatsu I, Tatematsu S, Saruta T.

Hypertension. 2004 Mar;43(3):603-9. Epub 2004 Feb 9.

PMID:
14769805
28.

C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation.

Kamao M, Tatematsu S, Hatakeyama S, Sakaki T, Sawada N, Inouye K, Ozono K, Kubodera N, Reddy GS, Okano T.

J Biol Chem. 2004 Apr 16;279(16):15897-907. Epub 2004 Feb 2.

29.

Differing anti-proteinuric action of candesartan and losartan in chronic renal disease.

Matsuda H, Hayashi K, Homma K, Yoshioka K, Kanda T, Takamatsu I, Tatematsu S, Wakino S, Saruta T.

Hypertens Res. 2003 Nov;26(11):875-80.

30.

Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney.

Hayashi K, Ozawa Y, Wakino S, Kanda T, Homma K, Takamatsu I, Tatematsu S, Saruta T.

J Cardiovasc Pharmacol. 2003 Dec;42(6):697-702.

PMID:
14639089
31.

Altered renal microvascular response in Zucker obese rats.

Hayashi K, Kanda T, Homma K, Tokuyama H, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, Saruta T.

Metabolism. 2002 Dec;51(12):1553-61.

PMID:
12489067
32.

Two novel metabolic pathways of 22-oxacalcitriol (OCT). C-25 dehydration and C-3 epimerization and biological activities of novel OCT metabolites.

Kamao M, Tatematsu S, Hatakeyama S, Ozono K, Kubodera N, Reddy GS, Okano T.

J Biol Chem. 2003 Jan 17;278(3):1463-71. Epub 2002 Nov 1.

33.

Differential regulation of elevated renal angiotensin II in chronic renal ischemia.

Tokuyama H, Hayashi K, Matsuda H, Kubota E, Honda M, Okubo K, Takamatsu I, Tatematsu S, Ozawa Y, Wakino S, Saruta T.

Hypertension. 2002 Jul;40(1):34-40.

PMID:
12105135
34.

Impact of calcium antagonists on bleeding time in patients with chronic renal failure.

Hayashi K, Matsuda H, Honda M, Ozawa Y, Tokuyama H, Okubo K, Takamatsu I, Kanda T, Tatematsu S, Homma K, Saruta T.

J Hum Hypertens. 2002 Mar;16(3):199-203.

35.

Isolation, identification and biological activity of 24R,25-dihydroxy-3-epi-vitamin D3: a novel metabolite of 24R,25-dihydroxyvitamin D3 produced in rat osteosarcoma cells (UMR 106).

Kamao M, Tatematsu S, Reddy GS, Hatakeyama S, Sugiura M, Ohashi N, Kubodera N, Okano T.

J Nutr Sci Vitaminol (Tokyo). 2001 Apr;47(2):108-15.

PMID:
11508700
36.

Studies on hemorrhagic diathesis of experimental bovine bracken poisoning. II. Heparin-like substance level in blood.

Yamane O, Hayashi T, Sako S, Tatematsu S, Takeda K.

Nihon Juigaku Zasshi. 1975 Aug;37(4):341-7. No abstract available.

PMID:
1238858

Supplemental Content

Loading ...
Support Center